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Small extracellular vesicles convey 
the stress-induced adaptive 
responses of melanoma cells
Maria Harmati1,2, Edina Gyukity-Sebestyen1,2, Gabriella Dobra1,2, Laszlo Janovak3, 
imre Dekany3, Okay Saydam4, Eva Hunyadi-Gulyas  5, Istvan nagy  6, Attila farkas7, 
tibor pankotai8,9, Zsuzsanna Ujfaludi8,9, Peter Horvath1,10, Filippo piccinini11, Maria Kovacs1, 
tamas Biro12,13 & Krisztina Buzas1,9*
Exosomes are small extracellular vesicles (sEVs), playing a crucial role in the intercellular 
communication in physiological as well as pathological processes. Here, we aimed to study whether 
the melanoma-derived seV-mediated communication could adapt to microenvironmental stresses. We 
compared B16F1 cell-derived sEVs released under normal and stress conditions, including cytostatic, 
heat and oxidative stress. The miRNome and proteome showed substantial differences across the 
sEV groups and bioinformatics analysis of the obtained data by the Ingenuity Pathway Analysis also 
revealed significant functional differences. The in silico predicted functional alterations of seVs were 
validated by in vitro assays. For instance, melanoma-derived sEVs elicited by oxidative stress increased 
Ki-67 expression of mesenchymal stem cells (MSCs); cytostatic stress-resulted sEVs facilitated 
melanoma cell migration; all sEV groups supported microtissue generation of MSC-B16F1 co-cultures 
in a 3D tumour matrix model. Based on this study, we concluded that (i) molecular patterns of tumour-
derived sEVs, dictated by the microenvironmental conditions, resulted in specific response patterns 
in the recipient cells; (ii) in silico analyses could be useful tools to predict different stress responses; 
(iii) alteration of the seV-mediated communication of tumour cells might be a therapy-induced host 
response, with a potential influence on treatment efficacy.
Exosomes are small (30–200 nm)1 endosome-derived vesicles that are actively secreted into the extracellular 
environment from most cell types. Initially, exosomes were proposed to eliminate cellular waste, but it has been 
proven that they also play a key role in the intercellular communication between adjacent as well as distal cells 
through the horizontal transfer of lipids, proteins and nucleic acids. Over the past three decades, exosomes have 
surged to the forefront of cell biology research, and recently an increasing body of evidence indicates that this 
exosomal communication is a deliberate and highly orchestrated process. Clinical relevance of exosomes is also 
considerable, since they are associated with numerous physiological and pathological conditions, including can-
cer diseases2.
1Laboratory of Microscopic Image Analysis and Machine Learning, Institute of Biochemistry,  Biological Research 
Centre of the Hungarian Academy of Sciences, Szeged, Hungary. 2Doctoral School of Interdisciplinary Medicine, 
Faculty of Medicine, University of Szeged, Szeged, Hungary. 3Interdisciplinary Excellence Centre, Department 
of Physical Chemistry and Materials Science, University of Szeged, Szeged, Hungary. 4Department of Pediatrics, 
University of Minnesota, Minneapolis, USA. 5Laboratory of Proteomics Research, Institute of Biochemistry, 
Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary. 6Sequencing Platform, Institute 
of Biochemistry, Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary. 7Laboratory 
of Microbial Genomics, Institute of Plant Biology, Biological Research Centre of the Hungarian Academy of Sciences, 
Szeged, Hungary. 8Department of Biochemistry and Molecular Biology, Faculty of Science and Informatics, 
University of Szeged, Szeged, Hungary. 9Department of Oral Biology and Experimental Dental Research, Faculty of 
Dentistry, University of Szeged, Szeged, Hungary. 10Institute for Molecular Medicine Finland, University of Helsinki, 
Helsinki, Finland. 11Laboratorio di Bioscienze, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 
(IRST) IRCCS, Meldola, Italy. 12Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, 
Hungary. 13Hungarian Centre of Excellence for Molecular Medicine, Szeged, Hungary. *email: kr.buzas@gmail.com
open
2Scientific RepoRtS |         (2019) 9:15329  | https://doi.org/10.1038/s41598-019-51778-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
Tumours are not just insular masses of proliferating cancer cells; they are also complex tissues composed of 
cellular components, such as mesenchymal stem cells (MSCs), cancer-associated fibroblasts (CAFs), endothelial 
cells, immune cells as well as extracellular matrix (ECM) components, which establish the so-called tumour 
microenvironment (TME) surrounding the tumour cells. The TME does not only surround the tumour cells, it 
also actively contributes to tumour progression, which requires a continuous paracrine communication3,4. One 
of the possible candidates for intercellular communication might be exosomes, since several recent papers have 
emphasized the mediating role of exosomes in the tumour macro- and microenvironment4–6. Upon contact with 
recipient cells, tumour-derived exosomes alter their phenotypic and functional properties conveying molecular 
and genetic messages7.
Since malignant melanoma is one of the most aggressive cancers, the B16F1 mouse melanoma cell line was 
chosen as a tumour cell model for this study. Melanoma cells potentially disseminate from a relatively small pri-
mary tumour and form metastases in multiple sites, including the lung, liver, brain, bone and lymph nodes8. This 
high metastatic potential can be explained by the unique features of melanoma. For instance, melanoma cells are 
mesenchymal in nature ensuring that a larger percentage of cells can act as stem cells with self-renewal capacity. 
They share many antigens with vascular endothelial cells (vasculogenic mimicry) which enables them to survive 
in the circulation, and increases their migration and invasion capacity as well. Furthermore, melanoma-derived 
extracellular vesicles also have a crucial role in the rapid tumour progression8–12. They are capable to induce a 
tumour-favourable phenotype in the EV-recipient cells in the TME13 and the metastatic sites14,15. For instance, 
after re-education by exosomes, MSCs may promote tumour growth and metastasis16,17; fibroblast18 and endothe-
lial cells19 can promote angiogenesis. There are also a few papers about intrinsic stresses, such as low pH20- or 
hypoxia21-induced alterations of melanoma exosomes, and their ability to transfer drug resistance22. However, 
different extrinsic stress-elicited changes have not been elucidated yet.
Using a unique approach, this study compared changes in the vesicular information transfer of melanoma cells 
under different inducible stress conditions. Exosomes are complex information packages, and we consider them 
as message delivering units with specific molecular patterns, rather than putting emphasis on a few exosomal sig-
nal molecules. Following the guideline recommended by ISEV (International Society for Extracellular Vesicles), 
called MISEV2018 (Minimal information for studies of extracellular vesicles 2018)23, we refer to the isolated 
vesicles based on their size by using the term ‘small extracellular vesicles’ (sEVs), even though their exosomal 
characteristics are demonstrated.
To gain insights into the plasticity and role of sEVs under suboptimal conditions, we investigated cytostatic, 
heat and oxidative stress-induced alterations of the B16F1 mouse melanoma cell-derived sEVs. Clinical relevance 
of this study is highlighted by previous papers, since chemo- or radiotherapy were shown to increase the amount 
of circulating tumour-derived EVs24,25. Although chemotherapy provides long-term clinical benefits to patients, 
it may induce tumour-promoting host responses as well26. Furthermore, Keklikoglou et al. have shown that 
paclitaxel and doxorubicin elicit the production of pro-metastatic breast cancer-derived EVs27. Hyperthermia 
treatment involves increasing the target site temperature to induce thermic stress, which results in cancer cell 
cytotoxicity and immune response stimulation via immune cell activation. Therefore, hyperthermia may enhance 
the therapeutic efficacy in combined therapies28,29, but its impact on tumour exosome-mediated intercellular 
communication has not been described yet. To induce oxidative stress, we used Ag-TiO2 photocatalyst particles, 
which represent a high potential for therapeutic applications through antibacterial30,31, antifungal32 and antican-
cer33 activities. However, the effects of Ag-TiO2-based therapies on the vesicular communication have not been 
investigated yet.
Results and Discussion
In order to study the adaptive sEV-mediated communication under microenvironmental stress, we investi-
gated cytostatic, heat and oxidative stress-induced alterations of the B16F1 mouse melanoma cell-derived sEVs. 
After verification the exosomal characteristics of our sEV isolates, we optimized the cytostatic and oxidative 
stress treatment conditions by proliferation assay and established the protocol for heat stress based on literature 
data34 to expose the melanoma cells to sublethal stress conditions. Then, for the sEV production, we cultured 
the B16F1 cells under five different conditions in EV-depleted FBS-containing media; control cultures (Ctrl) 
received culture medium, cytostatic stressed cultures (Doxo) were treated with 0.6 µM doxorubicin, heat stressed 
cultures (Hs) were incubated at 42°C for 3 × 2 h, oxidative stressed cultures (Ag-TiO2) were treated with 2.5 µg/ml 
light-induced Ag-TiO2, and as a control of the oxidative stress (Ag Ctrl), additional cultures were treated with 
illuminated media (Table 1). After a 72 h stress exposure period of B16F1 cultures, sEVs were isolated from 
their supernatants, quantified by nanoparticle tracking analysis (NTA) and analysed by SOLiD sequencing and 
LC-MS/MS to determine the miRNome and proteome of sEVs. Functional differences between sEV groups were 
predicted first in silico using the Ingenuity Pathway Analysis (IPA) based on the protein and miRNA data, and 
then verified by in vitro experiments targeting tumour-related cellular functions, such as Ki-67 expression, cell 
cycle dynamics, migration capacity and microtissue generation of the recipient cells (Fig. 1).
Conditions Control 1 Cytostatic stress Heat stress Control 2 Oxidative stress
sEV donor cell cultures Ctrl Doxo Hs Ag Ctrl Ag-TiO2
Treatment — 0.6 μM doxorubicin 3 × 2 h at 42°C illuminated medium light-induced 2.5 μg/ml Ag-TiO2
Released sEV groups Ctrl sEV Doxo sEV Hs sEV Ag Ctrl sEV Ag-TiO2 sEV
Table 1. Treatment schedule of tumour cell cultures and the isolated sEV groups.
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Our oxidative stress model is based on the photocatalytic activity of the Ag-TiO2 particles31,35. During the 
process of photocatalysis under appropriate (exciting) wavelength, reactive hydroxyl radicals (OH·) are produced, 
which are primarily responsible for photooxidation of organic materials or inactivating bacteria36. Hydroxyl rad-
icals are the most reactive oxygen species and cause irreversible DNA damages which could lead to DNA degra-
dation in bacteria36. In our previous work, the amount of reactive hydroxyl radicals formed on Ag-TiO2 particles 
was determined by the hydrogen peroxide-induced luminol-dependent chemiluminescence reaction30. It was 
presented that concentration of the Ag-TiO2-produced OH· radicals was equivalent to 0.33 mM H2O2 after 20 min 
visible light illumination.
Descriptive statistics of sEVs released under different microenvironmental conditions. Isolated 
EVs fulfil the minimal experimental requirements for small extracellular vesicles (sEVs). First, to fulfil the min-
imal experimental requirements for extracellular vesicles, suggested in the MISEV201823, we characterised the 
B16F1 cell-derived extracellular vesicles isolated from conditioned media by differential filtration and ultracen-
trifugation. Presence of the vesicles in the sEV isolates was verified by atomic force microscopy (AFM), and size 
distribution of the isolated vesicle population was described by dynamic light scattering (DLS) with a Z-average 
of 78 nm. EV markers, such as CD63 and CD9 (transmembrane proteins), HSP70, Alix and TSG101 (cytosolic 
proteins), Calnexin (negative sEV marker) were investigated in the vesicle isolates and the donor cell lysates by 
Western blot (Supplementary Fig. S1).
Vesicle production of melanoma cells is elevated under stress conditions. Scanning electron microscopy (SEM) 
revealed spectacular morphological changes of the B16F1 cells in each stressed group (Doxo, Hs and Ag-TiO2) 
24 h after treatments (Fig. 2a, top panels). Taking advantage of the high magnification capacity of SEM, we were 
able to observe the surface structures of the cells as well (Fig. 2a, bottom panels). At a 20,000 × magnification, we 
discovered spherical, exosome-sized vesicles, which were present in higher numbers on the stressed cells com-
pared to the untreated Ctrl cells (pDoxo = 0.00297, pHs = 0.03928, n = 5; Fig. 2b).
Then, we isolated sEVs from conditioned media of the five groups of cell cultures and quantified by the 
NTA-based NanoSight Analysis. There was a significant increase in vesicle number per cell in the Doxo 
(20.2 ± 0.4 × 103; p = 0.00021) and the Hs (12.7 ± 3.8 × 103; p = 0.03006) groups compared to the Ctrl one 
(5.35 ± 0.7 × 103). The Ag-TiO2-treated cultures produced 13 ± 1.8 × 103 sEVs per cell, while production of the 
Ag Ctrl group was only 7.9 ± 1.6 × 103 sEVs per cell (n = 3, Fig. 2c). At the same time, stress conditions did not 
affect the size distribution of sEVs.
Other reports also demonstrated that cells, including tumour cells, release a higher amount of exosomes in 
response to different types of stresses37, such as hypoxia38, acidosis39, oxidative stress40, thermal stress40, radia-
tion41 and cytotoxic drugs42–44.
Concentration of the encapsulated doxorubicin under cytostatic stress is less than 10% of median lethal dose. To 
reveal if doxorubicin, used for cytostatic stress in 0.6 µM concentration, could be encapsulated into the vesicles, 
Doxo sEV isolates were analysed by fluorescence spectroscopy. Using the Ctrl sEVs as a background, the calcu-
lated doxorubicin concentration of the Doxo sEVs was 14.735 nM.
Based on the measurements, the Doxo sEV suspensions – used for treatment of recipient cells – contained 
only 8 ng/ml doxorubicin. Therefore, it cannot be excluded that sEVs may transfer doxorubicin to the recipient 
cells, but the doxorubicin content of Doxo sEVs is less than 10% of the median lethal dose (LD50 = 100 ng/ml) 
for mouse melanoma cells45.
Encapsulation of Ag-TiO2 nanoparticles into sEVs cannot be proven. To investigate the possibility of Ag-TiO2 
encapsulation into sEVs, we measured the size distribution of the nanoparticles by DLS. The mean particle size 
was around 255 nm during the whole studied time interval (Supplementary Fig. S2). This means that the initial 
Ag-TiO2 photocatalyst particles form aggregates because the primer size of the Ag-TiO2 particles is around 25 nm 
as seen in the TEM image in our previous paper46. Thus, DLS measurements did indicate particle aggregation in 
the used medium; however, it also can be seen that the size of these particle aggregates did not change during 
the experiments. These results suggest that the Ag-TiO2 particles cannot be transferred into the recipient cells in 
this aggregated form and they cannot contaminate the sEV isolates, since particles over 220 nm were eliminated 
during the isolation process.
We also tried to detect disaggregated Ag-TiO2 nanoparticles in the sEV isolates using chemiluminescence (CL) 
method and transmission electron microscopy (TEM). After photoirradiation of the Ag-TiO2, generated ROS 
can be detected by adding luminol, which emit light upon oxidation30. We compared the CL intensity of Ag-TiO2 
sEV lysates to an Ag-TiO2 calibration curve prepared in Ag Ctrl sEV lysate, but it was under the detection limit 
(0.25 µg/ml; Supplementary Fig. S2). Moreover, on TEM images we could not observe any internal structures of 
the sEVs or contaminating electron-dense nanoparticles in the Ag-TiO2 sEV isolate (Supplementary Fig. S2).
miRNome and proteome of the melanoma sEVs strongly depend on the microenvironmental conditions of the donor 
cells. Exosomes deliver a wide range of RNAs and proteins to convey messages to the recipient cells. Their 
molecular content correlates with the type and state of the donor cell2. In this study, we compared the miRNA and 
protein patterns of the sEV groups to show the influence of the microenvironment on these information packages.
A total of 254 miRNAs were identified by SOLiD sequencing with more than ten read counts; 35.04% of 
these miRNAs were detected in each sEV group, while 6.30%, 1.18% and 0.79% were exclusively detected in the 
Ag-TiO2, Ctrl and Doxo sEVs, respectively. Hs and Ag Ctrl sEV-specific miRNAs were not found (Fig. 3a, left 
panel). The proportion of the over- and underrepresented miRNAs under stress conditions was the highest in 
the Ag-TiO2 sEVs, where 53.41% of the detected miRNAs showed more than twofold changes compared to the 
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corresponding control (Fig. 3a, right panel). Results of the sequencing data were validated by qPCR on three major 
miRNAs of this study, i.e. mmu-miR-16-5p, mmu-miR-125b-5p and mmu-miR-29a-3p (Supplementary Fig. S3).
Using LC-MS/MS, a total of 216 proteins were detected with three or more peptides; 59.72% of these proteins 
were common to all sEV groups, and only a few unique proteins were found (Fig. 3b, left panel). Eight Hs sEV-specific 
Figure 1. Schematic illustration of the experimental workflow in six steps. B16F1 mouse melanoma cell-
derived sEVs were isolated and characterised by Western Blot (WB), atomic force microscopy (AFM) and 
dynamic light scattering (DLS). Then B16F1 cultures were treated in five different ways, and 72 h supernatants 
were harvested for sEV isolation. Vesicle samples were then analysed by nanoparticle tracking analysis (NTA) to 
determine the number of released sEVs, sequencing and LC-MS/MS to describe their miRNome and proteome. 
Ingenuity Pathway Analysis (IPA) was used to analyse data and predict the functional differences between 
sEV groups. This in silico predictions were tested in vitro on mesenchymal stem cell (MSC) and melanoma cell 
cultures and MSC-B16F1 3D co-cultures as well using Ki-67-specific immunocytochemistry, Cell-Clock cell 
cycle assay, wound healing assay, and 3D hanging drop technology. Abbreviation: n.ctrl-negative control. Figure 
was created with BioRender.com.
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proteins were identified; half of these had a chaperone function (HSBP1, SERPINH1, CCT5, CLU). The major impact 
of heat stress on the protein composition of sEVs was also evidenced by the high proportion of the over- and under-
represented proteins (52.21%) compared to the Ctrl sEV group. Cytostatic stress also resulted in dramatic and dis-
tinct changes in the protein content of vesicles. For instance, the proportion of proteins, which decreased below 
the detectable level was the highest (15.34%) in Doxo sEVs (Fig. 3b, right panel). Many of the commonly found 
proteins have a function in vesicular trafficking, membrane fusion or MVB biology which suggests they have a role 
in exosome biogenesis. There are also melanocyte-specific molecules, such as some melanin biosynthesis elements 
(DCT, MLANA, PMEL, TYR or TYRP1), and we found a several metabolism-, cytoskeletal organisation-, extracel-
lular matrix remodelling-related proteins, adhesion molecules, receptors and transporters, which may have a crucial 
role in tumour progression (Fig. 3c). Proteomics data were validated by Western blot, where a vesicular marker, the 
HSP70 and the MLANA showed similar signal intensity patterns to the LC-MS/MS data (Supplementary Fig. S4).
Our findings about the molecular cargo of sEVs are in accordance with previous studies, which also 
showed changes in the exosomal content upon exposure of the donor cells to external stimuli and stress con-
ditions41,44,47,48. Furthermore, Peinado et al.17 and Lazar et al.49, analysing protein composition of different mel-
anoma cell line-derived exosomes, also found melanocyte-specific proteins, transmembrane proteins, such as 
tetraspanins, transporters and receptors as well as MVB and endosomal pathway-related proteins, for instance 
ESCRT-associated proteins, annexins, cytoskeletal and small GTP-binding proteins17,49.
comprehensive in silico analysis of functional differences between sEV groups. Since the exo-
somal cargo is a complex information package containing a large number and wide variety of molecules, it may 
act on several biological processes in the recipient cells. In this study, we aimed to identify these biological pro-
cesses even for normal (Ctrl) B16F1 sEVs and also for the stress-exposed cell-derived ones. We performed bio-
informatics analyses to interpret the biological context of the obtained miRNA and protein data applying the 
IPA. This software is based on computer algorithms that analyse the functional connectivity of the molecules 
using the Ingenuity Knowledge Base. For these in silico analyses, we set the confidence level to ‘Experimentally 
observed’ that enables literature data-based analysis, but not unproven predictions. Phrases between apostrophes 
are ‘IPA-specific terms’ in this paper.
Using the ‘Core analysis’ feature, we found a huge overlap in the ‘Top 5 canonical pathways’ between sEV 
groups. Namely, ‘Gycolysis I’, ‘Gluconeogenesis I’, ‘Eumelanin Biosynthesis’ and ‘Phagosome maturation’ was listed 
Figure 2. Microenvironmental stress factors resulted in morphological changes and elevated vesicle production 
of melanoma cells. (a) Scanning electron micrograph of the differently treated melanoma cells. The top row of 
pictures was taken in 1,500 × magnification showing the different cell morphology after 24 h treatments. The 
bottom row of pictures was taken in 20,000 × magnification showing the distinct cell surface structures. (b) The 
number of counted exosome-sized vesicles on the surface of cells using ImageJ (n = 5). (c) Number of released 
vesicles/cell based on NanoSight measurements (n = 3). Each bar represents mean + SD; *p < 0.05, **p < 0.01 
and ***p < 0.001 indicate statistical significance.
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in all five cases, while ‘Inhibition of matrix metalloproteinases’ (MMPs) was only found in Ctrl sEVs, and ‘EIF2 
signalling’ was listed in the four other sEV groups (Fig. 4a). As it was shown in the previous section, beside the 
remarkable differences, sEVs contain many donor cell-specific molecules, which helps to interpret these results. 
For instance, the Warburg effect, which means, that cancer cells may prefer metabolism via aerobic glycolysis 
rather than oxidative phosphorylation50,51 gives a possible explanation for the strong presence of glycolysis and 
glyconeogenesis-related molecules in sEVs. Since the investigated B16F1 is a melanin-producing cell line, the reason 
for the presence of the eumelanin biosynthesis-related molecules is obvious. Vesicular processes of exosome biogen-
esis52 account for the high number of phagosome maturation-related molecules in the isolated vesicles. Presence of 
the MMP- and EIF2 signalling-related molecules in the sEVs can also be explained by the tumour cell origin53–55.
Figure 3. Stress factors caused unique molecular patterns of the melanoma-derived sEVs. (a,b) Results of the 
miRNA sequencing and whole proteome analysis by LC-MS/MS. Venn diagrams show the number of common 
and unique molecules of the different sEVs. Stacked bar graphs show the distribution of sEV molecules based 
on their changes compared to the appropriate control. (c) Classification of the common proteins for each sEV 
group based on their function and localisation in vesicles.
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‘Top 5 molecular and cellular functions’ also showed similarities across the sEV groups. ‘Cellular develop-
ment’, ‘Cellular growth and proliferation’, ‘Cell death and survival’ and ‘Cellular movement’ were shared between 
each sEV group; ‘Protein synthesis’ was listed in Doxo and Hs sEVs and ‘Cell-to-cell signalling and interaction’ 
Figure 4. IPA showed that sEVs may influence many biological pathways and functions with different 
significance via their miRNA and protein content. (a) ‘Top 5 canonical pathways’ for each sEV group. Red 
values label the significance of pathways, which were not included in the Top 5. (b) ‘Top 5 molecular and 
cellular functions’ for each sEV group. Red values label the significance ranges of functions, which were not 
included in the Top 5. (c–f) Heatmaps from the ‘Comparison analysis’ of the molecular content of vesicles. 
Relevant ‘Biofunctions’ with -log(p-value) > 5 were organised into four groups, namely intracellular, cellular, 
systemic and immune processes.
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in Ctrl, Ag Ctrl and Ag-TiO2 ones (Fig. 4b). All of these cellular functions are involved in tumour progression, 
which highlights the role and diverse effects of vesicles in recipient cell reprogramming in the tumour matrix and 
the metastatic sites4–7,56–58.
Performing ‘Comparison analysis’ in the IPA, we built a heatmap of the melanoma-related ‘Diseases and 
Biofunctions’, significantly influenced by any sEV group (-log(p-value) > 5). This in silico analysis revealed that 
the sEVs may play a role not only in intracellular and cellular, but in systemic and immunological processes as 
well (Fig. 4c–f). Focusing on the activation and inhibitory effects, we identified many ‘Biofunctions’, which may 
be regulated differently by the sEVs, highlighting the role of the releasing conditions in the vesicular communi-
cation of melanoma cells. In order to prove the tumour-associated functional differences between sEV groups, 
some ‘Biofunctions’ related to stem cell proliferation, cell cycle, migration of tumour cells and aggregation of cells 
were selected for in vitro investigations.
In silico predictions-based in vitro analyses of seV-induced cellular responses in tumour matrix 
cells. In regulation-focused examinations using the LC-MS/MS and SOLiD sequencing data, the ‘Grow tool’ of 
IPA enabled to identify the interacting vesicular molecules for the investigated ‘Biofunctions’. Then, the ‘Molecule 
Activity Predictor’ (MAP) feature of IPA predicted their overall regulatory effects for each sEV group. Following 
these in silico studies, predicted alterations of the sEV-induced cell responses were analysed experimentally by 
in vitro methods. Proliferation, cell cycle dynamics, migration capacity and microtissue generation of the sEV 
recipient cells were investigated by Ki-67 immunocytochemistry, Cell-Clock cell cycle assay, wound healing assay 
and hanging drop technology, respectively.
Ag-TiO2 sEVs facilitate proliferation of mesenchymal stem cells. As an important element of the TME, the MSCs 
can be targeted by the tumour-derived extracellular vesicles. Therefore, we investigated the effects of the differ-
ent sEVs on stem cells. First, the in silico analyses predicted activation of Ki-67 expression for the Ctrl, Hs and 
Ag-TiO2 sEVs, and activation of ‘Proliferation of stem cells’ for each sEV group. These predictions suggest that 
after internalisation by stem cells, each of the investigated sEV groups may induce cell divisions and three of 
them could result in Ki-67 upregulation, if the delivered vesicular cargo is active in the recipient cells (Fig. 5a). 
According to the IPA analyses, the key B16F1 vesicular regulator of the Ki-67 expression may be the aldo-keto 
reductase family 1 member B1 (AKR1B1), which is known to be involved in glucose metabolism, osmoregulation, 
detoxication of lipid aldehydes59, oxidative stress signalling, activation of NF-κB and expression of adhesion mol-
ecules, such as ICAM or VCAM. It has recently been shown that inhibition of AKR1B1 prevented proliferation 
and expression of Ki-67 in the human umbilical vein endothelial cells (HUVEC)60. The IPA-predicted activa-
tion of ‘Proliferation of stem cells’ might be enhanced for instance by fibronectin (FN1)61, which was previously 
described by Sharma et al. to increase the growth of embryonic stem cells61 (Fig. 5a).
To test the differences in the Ki-67 regulation across sEV groups, we treated MSC cultures with 200 µg/ml 
sEV suspensions or PBS buffer as a negative control. After 24 h or 72 h of vesicle exposures, the Ki-67 expres-
sion was investigated by immunocytochemistry. For the quantitative evaluation of the experiment, the Operetta 
high-content imaging system and an image analysis and machine learning software (SCT Analyzer 1.0)62 was 
applied, which enabled to analyse almost 1.6 × 105 cells within a few hours. Our computer-assisted image analysis 
pipeline was comprised of cell segmentation, feature extraction and machine learning modules, where we had 
a training set with two classes for the Ki-67 positive and the negative cells. Compared to the negative control 
group, Ag-TiO2 sEVs significantly increased the proportion of Ki-67 positive cells after 72 h (p = 0.03572, n = 4; 
Fig. 5b,c).
Proliferation of MSCs was also tested by direct cell counting, where all of the cells in the sEV-exposed cell cul-
tures were counted using DAPI staining, imaging and machine learning. Results showed increased proliferation 
of cells upon exposure to Hs and Ag-TiO2 sEVs as early as 24 h, but different sEVs each had a distinct influence 
on this cell function (Fig. 5d).
Our in vitro results suggest that melanoma sEVs released under different microenvironmental conditions may 
have distinct effect on stem cell proliferation. However, beside the IPA predicted interactions, additional mole-
cules and factors, such as the encapsulated doxorubicin, may also be involved in this process.
Previously, tumour exosomes derived from melanoma cells17, osteosarcoma cells63 or breast cancer cells64 
have been shown to re-educate MSCs and provide them tumour-promoting properties. The tumour-educated 
stem cells may go through an oncogenic reprogramming resulting in increased proliferation capacity in vitro, 
and tumour growth- and metastasis progression-supporting effects in vivo. Here, we also observed an increase in 
the proliferation and Ki-67 expression upon the normal (Ctrl) sEV exposure. However, our results suggest that 
the stem cell re-education capacity of vesicles strongly depends on the microenvironmental conditions of the 
releasing tumour cells.
Doxo and Ctrl sEVs affect the cell cycle of melanoma cells. IPA analyses predicted inhibition of ‘G1 phase of 
tumour cell lines’ and ‘G1/S phase transition of tumour cell lines’ upon exposure to Ctrl, Doxo and Hs sEVs 
(Fig. 6a). In other words, the molecular content of these vesicles may cause an arrest in the G1 phase in recip-
ient tumour cells. As displayed on Fig. 6a, IPA found a total of 15 sEV molecules in our B16F1 data, which 
may influence the G1 phase of tumour cell lines. Hypothetically, the key player of their inhibitory effect may be 
the aspartyl-tRNA synthetase (DARS). In 1999, Yamashita et al.65 investigated T24 bladder carcinoma cells and 
showed that DARS causes a retinoblastoma-independent downregulation of cyclin A, which is required for S 
phase entry65. Another component of the B16F1 vesicles, the p53 inducible miR-34a may lead to apoptosis and 
cell cycle arrest in the G1 phase, thereby suppressing tumour cell proliferation66. Ji et al.67 showed that restoration 
of miR-34 expression in pancreatic cancer cells inhibited cell growth and invasion, induced apoptosis, arrested 
cell cycle in G1 and G2/M phases and sensitized the cells to chemotherapy and radiation67.
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To test the in silico predicted effects of sEVs on tumour cell cycle, we performed a Cell-Clock cell cycle assay 
on B16F1 melanoma cells exposed to sEVs for 24 h, 48 h and 72 h along with a PBS-treated negative control group. 
This assay utilizes a vital redox dye that changes colour based on the cell cycle phase. It becomes yellow in G1, 
Figure 5. Stress-exposed melanoma cell-derived vesicles affected the proliferation of MSCs. (a) IPA predictions 
for the regulatory effects of sEV molecules on Ki-67 expression and ‘Proliferation of stem cells’. Networks show 
every upstream regulator proteins accompanied by a bar graph, which represents the normalised expression 
values of the molecule for each sEV group. Coloured symbols, named as the sEV groups, display the expected 
regulation changes of the analysed ‘Molecule’ and ‘Biofunction’ upon exposure to the vesicles. (b,c) Evaluation 
of the Ki-67-specific immunocytochemistry using an image analysis and machine learning software. (b) Images 
are representatives of the classified ones. Yellow and blue dots show the Ki-67 positive and negative nuclei, 
respectively. (c) Bar graphs show percentages of the Ki-67 positive cells 24 h (left panel) and 72 h (right panel) after 
sEV exposures. Each bar represents mean + SD (n = 4). (d) Cell numbers of the sEV-exposed cells after 24 h and 
72 h incubation time. Bar graphs represent mean + SD values (n = 3), *p < 0.05 indicates statistical significance.
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green in S/G2 and blue in M phase. In the negative Ctrl group, cells were present in the G1, S/G2, and M phases in 
average proportions of 44.84 ± 2.68%, 47.80 ± 3.34% and 7.35 ± 0.81%, respectively (n = 12). Ctrl and Doxo sEVs 
led to an increase in the proportion of the yellow, i.e. G1 phase, cells in a time dependent manner. After 72 h, these 
cells represented 59.20 ± 4.06% of the Ctrl sEV-exposed cultures (p = 0.00346, n = 4) and 70.32 ± 7.24% of Doxo 
sEV-exposed cultures (p = 4.28 × 10−6, n = 4) (Fig. 6b,c). These results confirmed the IPA predicted arrest in G1 
phase by the Ctrl and Doxo, but not by the Hs sEVs.
It has been previously demonstrated that tumour cells can efflux drugs through exosome secretion43,68. Yang 
et al. showed that doxorubicin-treated MCF-7 breast carcinoma cells produced drug-containing exosomes. 
Doxorubicin that was encapsulated in the MCF-7 exosomes had more potent cytotoxicity against the parental 
MCF-7 cells than the free drug43. Furthermore, doxorubicin arrest the cell cycle of tumour cells at G1/S and G2/M 
checkpoints69,70. Based on these literature data and our fluorescence spectroscopy measurements, we hypothesize 
that encapsulated doxorubicin might contribute to the enhanced cell cycle arrest effect of Doxo sEVs.
Figure 6. Ctrl and Doxo sEVs caused an arrest in G1 phase of melanoma cells. (a) IPA predictions for the 
regulatory effects of sEV molecules on the ‘G1 phase of tumour cell lines’ and ‘G1/S phase transition of tumour 
cell lines’. Networks show every upstream regulator proteins and miRNAs accompanied by a bar graph, which 
represents the normalised expression values of the molecule for each sEV group. Coloured symbols, named 
as the sEV groups, display the expected regulation changes of the analysed ‘Biofunctions’ upon exposure to 
the vesicles. (b,c) Cell-Clock cell cycle assay of sEV-exposed B16F1 cell cultures. (b) Representative images 
of the cell clock dye-labelled cultures. (c) Distribution of the yellow, green and blue cells in the cell cultures, 
which labels the G1, G2/S and M phase cells, respectively. Each bar represents mean + SD (n = 4), *p < 0.05, 
**p < 0.01 and ***p < 0.001 indicate statistical significance.
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Migration capacity of melanoma cells is differently altered by the sEVs. From many cell movement-related 
‘Biofunctions’, which were predicted to be targeted by sEVs (Fig. 4d–f), we chose the ‘Migration of melanoma cell 
lines’ for further IPA and in vitro investigations. The in silico analyses showed varying sEV effects. More specifi-
cally, Doxo and Ag-TiO2 sEVs are predicted to facilitate the melanoma cell migration, while the three other ones 
may inhibit this function (Fig. 7a). According to the IPA analyses, negative B16F1 sEV regulators may include the 
laminin subunit alpha-5 (LAMA5), peroxiredoxin-2 (PRDX2), tyrosinase (TYR), let-7a-5p, miR-125b-5p and the 
miR-34a-5p. Listed positive regulators include the CD44 antigen (CD44), CD81 antigen (CD81), basigin (BSG), 
integrin beta-1 (ITGB1) and the galectin-3-binding protein (LGALS3BP) (Fig. 7a). Using attachment and pul-
monary metastases assays, Hibino et al.71 identified four peptides of LAMA5, which showed activity in vitro and 
also in vivo. These peptides reduced migration and invasion of B16F10 melanoma cells71. Lee et al.72 showed that 
the PRDX2 enzyme is a selective antioxidant suppressor for proliferation and migration of melanoma cell lines 
(SK-MEL-5, SK-MEL-28, A375, G361, B16F10)72. Stampolidis et al. demonstrated that LGALS3BP promotes cell 
viability and facilitates cell motility of the human C8161 melanoma cell line73.
Using wound healing assay, we investigated the effect of sEVs on migration of B16F1 cells, which approxi-
mated to the IPA predicted tendency. Migration of cells into the wounded area was slightly decreased in the pres-
ence of Ctrl and Ag Ctrl sEVs, compared to migration of the negative Ctrl cells. Acceleration of wound closure 
was observed in response to Doxo sEVs (n = 8). However, Hs and Ag-TiO2 sEVs had no effect on tumour cell 
migration (Fig. 7b,c).
The importance of migration capacity in tumour progression is unquestionable, since the process of tumour 
cell invasion and metastasis is conventionally understood as the migration of individual cells, which detach from 
the primary tumour, enter lymphatic vessels or the bloodstream and seed in distant organs74. This cancer cell 
migration is typically regulated by integrins, matrix-degrading enzymes, cell-cell adhesion molecules and cell-cell 
communication74. Direct and indirect effects of stress-elicited sEVs on tumour cell migration and metastasis 
Figure 7. Doxo sEVs enhanced the migration of melanoma cells. (a) IPA predictions for the regulatory effects 
of sEV molecules on the ‘Migration of melanoma cell lines’. Network shows every upstream regulator proteins 
and miRNAs accompanied by a bar graph, which represents the normalised expression values of the molecule 
for each sEV group. Coloured symbols, named as the sEV groups, display the expected regulation changes of 
the analysed ‘Biofunction’ upon exposure to the vesicles. (b,c) Wound healing assay of sEV-exposed B16F1 cell 
cultures. (b) The bar graph shows the result of the analysis of wound closures by the ImageJ wound healing tool. 
It represents mean + SD values (n = 8). (c) Representative images of the wounds after 48 h of sEV exposures.
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have been demonstrated in some studies27,47,75. Here, we amended literature data by showing that the cytostatic 
stress-exposed cell-derived sEVs enhance the migration of the recipient melanoma cells. This can be interpreted 
as an adaptive escape mechanism: Doxo sEVs, delivering a warning message, induce the migration of the neigh-
bouring melanoma cells. In a recent study27, breast cancer cells also showed an sEV-mediated escape mechanism 
under doxorubicin and paclitaxel exposures, by releasing pro-metastatic exosomes27.
Each sEV group enhances the migration of endothelial cells. IPA predicted the activation of ‘Cell migration of 
endothelial cells’ and ‘Cell spreading of endothelial cells’ upon exposure to each sEV group labelling a large num-
ber of potentially contributing sEV molecules (Supplementary Fig. S5). Therefore, we repeated the wound healing 
assays on bEnd.3 mouse endothelial cells, where we could verify the IPA predictions. However, Ctrl sEVs showed 
the highest migration enhancing effect (Supplementary Fig. S5).
Endothelial cell migration is an essential component of angiogenesis, which is a key process of tumour pro-
gression76. These results demonstrate that some type of stress conditions may slightly decrease the endothelial 
cell migration promoting effects of sEVs. At the same time, they highlight that sEVs may have target cell-specific 
functional effects in the recipients, which further increases the diversity of the sEV-mediated communication of 
melanoma cells.
Microtissue generation is facilitated independently of the sEV groups. IPA predicted that each of the five sEV 
groups may activate many ‘Biofunctions’ related to the formation of a 3D cell interaction matrix, e.g. ‘Aggregation 
of cells’, ‘Formation of ECM’ (Fig. 8a), ‘Cell-cell contact’ or ‘Interaction of tumour cell lines’ (Supplementary 
Fig. S6). The intensity of these activations is variable between sEV groups, for example activation of the 
‘Aggregation of cells’ is predicted to be the strongest upon Doxo and Hs sEV exposures. In silico analyses revealed 
a large number of contributing B16F1 sEV molecules. For instance, it is worth to mention the programmed cell 
death 6-interacting protein (PDCD6IP, Alix). It has an important role not only in the exosome biogenesis52, but 
Pan et al.77, who investigated fibroblast morphology, demonstrated that a sub-population of Alix localises extra-
cellularly and regulates integrin-mediated cell adhesions and fibronectin matrix assembly77.
In order to mimic in vivo conditions, we established a simplified 3D tumour matrix model co-culturing MSCs 
and B16F1 cells in hanging drop plates. By definition, multicellular cell aggregates, which produce their own 
ECM and are comprised of more than one cell types are termed as microtissues78. Applying an equal number of 
the two cell types (a total of 5,000 cells/well), microtissue generation was followed under sEV exposures and PBS 
treatment as a negative control for 72 h. The created microtissues were photographed and analysed by the AnaSP 
software developed for automatic image analysis of multicellular spheroids79. Each group of sEVs resulted in 
smaller and more compact microtissues, since the average values of the measured area, perimeter, diameter and 
volume was lower, compared to the negative Ctrl samples (Fig. 8b–d). These results were validated using mouse 
embryonic fibroblasts (MEFs) co-cultured with B16F1 cells, where each sEV group facilitated the microtissue 
generation, except the Hs sEVs (Supplementary Fig. S7).
In videomicroscopy studies, Crawford et al.80 observed that microvesicles attaching to the cell membranes 
promoted cell-to-cell interactions and spheroid formation of glioblastoma, breast carcinoma and osteosarcoma 
cells. They also showed that elevated extracellular Ca2+ levels promote microvesicle production and result in 
smaller and less dense spheroids, which might seem paradoxical. However, they interpreted their results as a 
pathophysiological adaptation, since increasing spheroid surface to volume ratio, thereby increasing the surface 
area enhances the uptake of oxygen, growth factors and nutrients by tumour cells that make up the spheroid 
mass80. In our experimental setup, sEV exposures resulted in smaller microtissues from the same number of cells 
suggesting the generation of more compact structures, which may be explained by the role of vesicles in genera-
tion of cell-cell associations, and may also indicate an adaptation mechanism.
Tumours exist in a 3D microenvironment, in which morphological and functional properties, such as the 
ECM, cell-cell interactions, oxygen gradient and acid gradient create transport barriers for drug delivery81. In 
this study, Doxo sEV exposure resulted in the most compact structures, which may reduce penetration of drugs. 
Previously, tumour-derived extracellular vesicles have been shown to transfer drug resistance into other tumour 
cells82,83 suggesting that the Doxo sEVs might convey protective messages resulting in more compact microtissues.
conclusions
In this study, we compared different inducible cellular stress conditions, and we found that cytostatic, heat and 
oxidative stresses resulted in changes in the vesicular cargo composition, leading to distinct functional alterations 
of the melanoma-derived sEVs in the TME recipient cells.
We showed that sEVs, being complex information packages may participate in a wide range of signalling path-
ways. The fact that a vesicular molecular pattern with a large number of molecules can influence the activation of 
the cellular homeostasis network at several points, suggests a huge diversity of sEV functions, which sometimes 
seem to be paradoxical in the in vitro experiments. In conclusion, hundreds of vesicular molecules may have 
thousands of functional effects in the recipient cells leading to an unconceivable outcome. Here, we successfully 
predicted the functional effects of the investigated sEV molecular patterns – induced by five treatment conditions 
– by bioinformatics analyses using unique combinations of the IPA approaches. Based on our knowledge, our 
experimental setup was suitable to model the transfer and functional activity of the vesicular cargo in the recip-
ient cells. Here, we demonstrated, that pathway analyses may provide a good approximation to the prediction of 
different inducible stress-elicited responses, suggesting that in silico analyses may be useful tools not only in the 
field of research, but in a therapeutic approach as well.
Our paper not only provides a detailed characterisation of the doxorubicin-, heat- and Ag-TiO2-induced 
molecular patterns of melanoma-derived sEVs and the resulted response patterns in the recipient cells, it also 
increases our knowledge about the molecular and functional complexity as well as condition-dependent variability 
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Figure 8. All sEV groups facilitated microtissue generation. (a) IPA predictions for the regulatory effects of 
sEV molecules on the ‘Aggregation of cells’ and the ‘Formation of extracellular matrix’. Networks show every 
upstream regulator proteins and miRNAs accompanied by a bar graph, which represents the normalised 
expression values of the molecule for each sEV group. Coloured symbols, named as the sEV groups, display 
the expected regulation changes of the analysed ‘Biofunctions’ upon exposure to the vesicles. (b,c) Descriptive 
statistics of the 72 h B16F1-MSC microtissues resulted from image analysis using the AnaSP software. Eq. 
diameter means equivalent diameter, major and minor diameters are measured through centroid. Table contains 
mean ± SD values. Bar graphs show the area, perimeter and volume statistics of the generated microtissues 
(mean + SD, n = 3). Statistical evaluation was performed by Welch’s ANOVA test with Tukey’s HSD post-hoc 
test; *p < 0.05, **p < 0.01 and ***p < 0.001 indicate statistical significance. (d) Representative images of the 
generated microtissues after 72 h of sEV exposures.
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of the melanoma-derived sEVs. This study contributes to a better understanding of the pathogenesis and therapeu-
tic responses of melanoma. It also highlights that indirect effects of any therapy, such as a chemotherapy, may have 
a great influence on the intercellular communication of the affected cells.
Based on this study, we conclude that the molecular pattern of these highly protected information packages 
is dictated by the microenvironmental conditions, including the therapeutic stress factors. The altered cargo of 
sEVs is able to not only enhance or suppress existing signalisation pathways, but even trigger de novo pathway 
activations, resulting a unique target cell-specific response pattern in the sEV recipient cells. Recent literature 
data24,25,27,47 along with this study suggest that alteration of this complex sEV-mediated intercellular communi-
cation of tumour cells deserves special attention among the therapy-induced host responses, which may have a 
potential influence on the treatment efficacy.
Methods
cell cultures. B16F1 (ECACC 92101203) mouse melanoma cell line was obtained from ECACC and cul-
tured in DMEM supplemented by 10% FBS (EuroClone), 2 mM L-glutamine and 1% Penicillin-Streptomycin-
Amphotericin B mixture (P/S/A; all from Lonza); mouse embryonic fibroblasts (MEFs; ATCC SCRC-1040) were 
obtained from ATCC and cultured in DMEM supplemented by 15% FBS and 1% P/S/A; bEnd.3 mouse endothe-
lial cell line (ATCC CRL-2299) was obtained from ATCC and cultured in DMEM supplemented by 10% FBS and 
1% P/S/A. Primary mouse mesenchymal stem cells (MSCs) were isolated from adipose tissue of 6-8 week old 
male C57BL/6N mice (Charles River Laboratories) and cultured using the MesenCult Expansion Kit (STEMCELL 
Technologies). All cell cultures were maintained in a humidified incubator at 37°C and 5% CO2. Purity of MSC 
cultures was checked by flow cytometry using the Mouse Multipotent Mesenchymal Stromal Cell Marker 
Antibody Panel (R&D Systems) according to the manufacturer’s instructions and a FACSCalibur instrument 
coupled with CellQuest Pro 6.0 (BD Biosciences). Animal experiments were performed in accordance with the 
national and European animal ethics guidelines. The animal experimental protocols were approved by the Animal 
Experimentation and Ethics Committee of the Biological Research Centre of the Hungarian Academy of Sciences 
and the Hungarian National Animal Experimentation and Ethics Board (clearance number: XVI./78/2018).
Ag-TiO2 photocatalyst particles. Synthesis of Ag-TiO2 nanoparticles was performed as published ear-
lier31,35. Briefly, the silver particles were strongly attached on the surface of metal oxide by photodeposition. A 
commercially available TiO2 (Degussa P25, Evonik Gmbh) with a specific surface area of ~50 m2/g was used for 
this purpose. The prepared Ag-TiO2 photocatalyst contained 0.5 wt% surface silver nanoparticles. Dispersion of 
particles was made in PBS at a concentration of 10 mg/ml and sonicated for 30 min directly before use.
Stress conditions. B16F1 cell cultures were treated at 70% confluency in five different ways in EV-depleted 
FBS-containing media for 72 h (Table 1). The Control 1 group received only fresh medium. Cytostatic stressed 
cells were treated with 0.6 μM doxorubicin, heat stressed cells were incubated at 42°C for 2 h in every 24 h (a total 
of 3 times), oxidative stressed cells were treated with light-induced 2.5 μg/ml Ag-TiO2. In detail, the photore-
active Ag-TiO2 nanoparticles were induced by a low-pressure mercury lamp (λ ≥ 360 nm, GCL303T5/4 type, 
LightTech) for 60 min from 3 cm distance in a 75% medium volume to avoid the light absorption and reflection 
of the medium layer. After the illumination, the medium was adjusted to the final volume. To eliminate the effect 
of illumination itself, we established another control group, which received medium illuminated in the same way 
as described above. Parameters of the cytostatic and oxidative stresses were based on previous optimization by 
proliferation assay. Heat stress conditions were adapted from literature data34. In each group, 72 h supernatants of 
6 parallel cell cultures were harvested, pooled and subjected to sEV isolation.
Scanning electron microscopy (SeM). B16F1 cells seeded to poly-L-lysine-coated 5 mm cover glasses were 
treated as described above. After 24 h incubation, cells were washed with PBS and fixed for overnight in 2.5% glutar-
aldehyde and 0.05 M cacodylate buffer diluted in PBS (pH 7.2). Then, cells were washed with PBS, dehydrated with a 
graded ethanol series (30%, 50%, 70%, 80% EtOH, each for 1 h and 100% EtOH, for 3 × 1 h) and dried with a critical 
point dryer (Quorum Technologies Ltd, K850). Cover glasses were mounted onto microscope stubs using carbon 
tape, followed by 15 nm gold coating (Quorum Technologies Ltd, Q150) and observed under a field-emission scan-
ning electron microscope (JEOL Ltd, JSM-7100F/LV). Images were taken in 1,500 × and 20,000 × magnification.
seV isolation and characterisation. Vesicles were isolated by differential filtration and ultracentrifuga-
tion. Briefly, 72 h supernatants from the stress-exposed B16F1 cultures were centrifuged at 780 g for 5 min, and 
at 3,900 g for 15 min at 4°C, then filtered by a 0.2 µm membrane to remove cells, debris and larger vesicles. Small 
EVs were pelleted by ultracentrifugation at 150,000 g for 60 min at 4°C using a T-1270 fixed-angle rotor and a 
WX + ultracentrifuge (Sorvall). The pellet was washed twice and resuspended in PBS. Protein concentrations of 
sEV isolates were measured by the Pierce BCA Protein assay kit (Thermo Scientific) on a benchtop microplate 
reader (Multiskan RC, Thermo Labsystems) coupled with the Ascent Software 2.6. Small EVs were character-
ised by atomic force microscopy as described previously44, dynamic light scattering using a Zetasizer Nano S 
instrument (Malvern Panalytical Ltd) and Western blot analysis (described in the Supplementary Methods). 
Quantification of sEVs was performed by nanoparticle tracking analysis using a NanoSight NS500 instrument 
(Malvern Panalytical Ltd).
fluorescence spectroscopy. The emission and excitation spectra of doxorubicin were measured by a 
FluoroLog-3 spectrofluorometer (Horiba Ltd). The maximum wavelengths for excitation (λex = 492 nm) and 
emission (λem = 592 nm) were then used for measuring the fluorescence intensity of Doxo sEVs and Ctrl sEVs as 
a background. A calibration curve of doxorubicin covering a concentration range of 0-1,000 nM was applied to 
determine the encapsulated doxorubicin concentration of the sEV samples.
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Dynamic light scattering (DLS) measurements of Ag-TiO2 particles. The particle size values of the 
Ag-TiO2 photocatalyst particles were determined DLS with a Zetasizer Nano ZS ZEN 4003 apparatus (Malvern 
Panalytical Ltd) equipped with a He-Ne laser (λ = 633 nm). The measurements were performed in B16F1 culture 
medium for a 72 h time interval. Size distribution measurements were carried out in triplicate, and mean ± SD 
values are reported.
Chemiluminescence detection of Ag-TiO2 nanoparticles. Isolated Ag Ctrl and Ag-TiO2 sEVs were 
lysed by TENT buffer and freeze-thaw cycle, then a 10-fold, 5-step Ag-TiO2 nanoparticle dilution series (0–2.5 µg/
ml) was prepared in Ag Ctrl sEV suspension for calibration. Protein concentration of sEV lysates was 200 µg/ml. 
After 30 min illumination on 96-well plates, 50 µl 3.38 mM luminol solution was added to 50 µl of samples and 
light emission was immediately detected by a Luminoskan Ascent Microplate Luminometer (Thermo Scientific). 
Each sample was measured in triplicates.
transmission electron microscopy (teM). The morphology of Ag-TiO2 sEVs and Ag-TiO2 sEVs mixed 
with Ag-TiO2 nanoparticles was examined using a Tecnai G2 20 × -Twin type instrument (FEI), operating at an 
acceleration voltage of 200 kV. For TEM measurements the samples were dropped on a grid (carbon film with 200 
Mesh coper grids; CF200-Cu, Electron Microscopy Sciences) and dried.
miRNA analysis of sEVs. Pellets of sEVs were subjected to miRNA isolation using the NucleoSpin miRNA 
isolation kit (Macherey-Nagel) according to the manufacturer’s instructions. Sequencing was performed using 
SOLiD Total RNA-Seq lit for Small RNA Libraries (Applied Biosystems) based on the manufacturer’s protocol. 
Purification was performed on 10% TBE-Urea gels stained with Sybr Gold nucleic acid gel stain (both from 
Invitrogen). Final purification was performed using PureLink PCR Micro Kit (Invitrogen). Final libraries were 
quality checked using High Sensitivity DNA kit on Bioanalyzer (Agilent Technologies). Concentration of the 
libraries was determined by the SOLiD Library TaqMan Quantitation Kit (Life Technologies). Each library was 
clonally amplified on SOLiD P1 DNA Beads by emulsion PCR (ePCR). Emulsions were broken using butanol, 
and ePCR beads were enriched for template-positive beads by hybridization with magnetic enrichment beads. 
Template-enriched beads were extended at the 3’ end in the presence of terminal transferase and 3’ bead linker. 
Beads with the clonally amplified DNA were deposited onto SOLiD sequencing slide and sequenced on SOLiD 
5500xl instrument using the 50-base sequencing chemistry.
Bioinformatics analysis of raw data, quality assessment, read trimming, read mapping and miRNA expression 
profiling was carried out in CLC Genomics Workbench 8.0.2 (Qiagen Bioinformatics) using annotated Mus mus-
culus miRNA sequences according to the miRBase release 21 as a mapping reference. Only miRNAs with ≥10 
read counts were accepted.
Results of sequencing were validated by qPCR on 3 selected miRNAs, mmu-miR-16-5p, mmu-miR-125b-5p, 
mmu-miR-29a-3p. Intact total RNA – including miRNA – were prepared from sEV isolates by miRNA Miniprep 
System (Promega) according to the manufacturer’s instructions. Then, 70 ng of each sample were reverse tran-
scribed using microRNA cDNA synthesis kit (Sigma-Aldrich). The qPCR reactions were performed on PikoReal 
Real-Time PCR System (Thermo Scientific) using SYBR Green chemistry and commercially available miRNA 
specific primers (Sigma-Aldrich). Cq values of each miRNA were normalized by U6 endogenous controls in all 
samples and expression levels were calculated using -ddCt method.
proteome analysis of seVs. Detailed LC-MS/MS analysis of sEVs is described in the Supplementary 
Methods. Briefly, 25 µg of vesicular proteins were separated by SDS-PAGE and stained with Coomassie blue. 
Then, each lane was cut to 12 equal bands and subjected to an in-gel trypsinisation procedure. The extracted 
peptides were analysed on an LTQ-Orbitrap Elite (Thermo Scientific) mass spectrometer on-line coupled with 
a nanoHPLC (nanoAcquity, Waters) system. Searchable peaklists were extracted using Proteome Discoverer 1.4 
(Thermo Scientific) and subjected to database search on our in-house Protein Prospector 5.14.1 search engine 
against the Mus musculus and Bos taurus protein sequences of the Uniprot (UniProtKB.06.11.2014) database 
completed with human keratins and pig trypsin, altogether 106,330 protein sequences were searched. Protein 
identification was accepted if the protein was identified with ≥3 unique peptides, but peptides with identical 
bovine and mouse sequence were excluded. FDR values were less than 1% in all cases. Results were validated by 
Western blot (described in the Supplementary Methods).
Bioinformatics analysis. Normalised miRNA and protein data derived from the LC-MS/MS and SOLiD 
sequencing were analysed by the Ingenuity Pathway Analysis (IPA, Qiagen Bioinformatics). First, we used the 
‘Core Analysis’ feature to reveal functional differences between the five sEV groups, where ‘Top 5 canonical path-
ways’ and ‘Top 5 molecular and cellular functions’ (Fig. 4a,b) were obtained. Secondly, using the ‘Comparison 
Analysis’ feature, we created a heatmap containing ‘Biofunctions’, which had relevance in melanoma and >5 
-log(p-value). This heatmap was divided into four parts based on biological relevance; intracellular, cellular, sys-
temic and immune processes are displayed in separated panels (Fig. 4c–f). Thirdly, some ‘Biofunctions’ were cho-
sen for further investigation to reveal the regulatory effects of sEVs on them. Using the ‘Grow tool’, the upstream 
interacting vesicular molecules were identified for the selected ‘Biofunctions’ for each sEV group. Then, using the 
‘Molecule Activity Predictor’ (MAP) tool, we could reveal the activation or inhibitory effects of each sEV group 
for each ‘Biofunction’ (Figs. 5–8a). Through these in silico analysis, we could model the effects of the different 
sEVs in the recipient cells in spite of their molecular complexity. Figures were edited in the IPA ‘Path Designer’ 
and completed with Excel diagrams. For all IPA analyses, the confidence level was set to ‘Experimentally observed’ 
enabling literature data-based analysis, but not unproven predictions.
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Exposures of MSCs and B16F1 cells to the sEVs. To avoid additional effects of changing conditions, 
cells were exposed to sEVs in their standard, complete media before each of the following functional assays. 
Briefly, cells were treated with 200 µg/ml sEV suspensions, or PBS as a negative control for 24 h, 48 h or 72 h. For 
longer incubation times, treatments were repeated in every 24 h.
Ki-67 expression analysis of MSCs. MSCs exposed to sEVs for 24 h and 72 h were fixed in 4% paraform-
aldehyde for 10 min at room temperature (RT) for immunocytochemistry. Then, cells were permeabilised with 
0.1% Triton X-100 and non-specific antibody binding was blocked with 5% BSA. We applied direct labelling 
using anti-mouse/rat Ki-67 monoclonal antibody conjugated to eFluor 615 dye (1:400, eBioScience) in 1.2% BSA 
overnight at 4°C. Nuclear counterstaining was performed with DAPI for 15 min at RT. Cells were washed 3 times 
with PBS for 5 min between each step. Finally, the cells were covered by Fluoromount-G (SouthernBiotech) and 
cover glasses. Fluorescent images were taken by the Operetta high content screening system (PerkinElmer) and 
analysed by an image analysis and machine learning software (SCT Analyzer 1.0) developed by the Single-Cell 
Technologies Ltd62. Our pipeline was comprised of cell segmentation, feature extraction and machine learning 
modules. K-means algorithm was used for the nuclei segmentation based on the DAPI signal, then we extracted 
the eFluor 615 signal-related features, i.e. max intensity, min intensity, mean intensity, median intensity, SD inten-
sity for the generated nuclei masks. We established a training set with two classes for the Ki-67 positive and the 
negative cells. This training set, containing 100 objects in both classes was validated by the implemented k-fold 
cross-validation. For machine learning, we used the Multi-Layer Perceptron (MLP) method. The Ki-67 expres-
sion analysis was repeated 4 times and the applied methods enabled to analyse a total of 159,596 cells.
cell counting. MSC cultures in 384-well plates were exposed to sEVs for 24 h and 72 h, then fixed in 4% 
paraformaldehyde for 10 min at RT and stained with 1 µg/ml DAPI for 15 min at RT. Images were acquired from 
whole wells using a TCS SP8 microscope (Leica Microsystems) in fluorescent mode, followed by an analysis using 
the SCT Analyzer 1.0 machine learning software. The experiment was repeated 3 times.
cell cycle analysis. Changes in the cell cycle dynamics of sEV-exposed B16F1 cells were analysed using the 
Cell-Clock cell cycle assay (Biocolor Ltd) according to the assay protocol. This assay can be used to distinguish the 
four major phases of the mammalian cell cycle using a vital redox dye, which is yellow, green or dark blue in G1, 
S/G2, and M phase cells, respectively. After staining, cells were photographed using an Axiovert S100 microscope 
(Zeiss) equipped by a Nikon D5000 camera. Images were analysed by the ImageJ software to determine the per-
centage of cells in each cell cycle phase. The experiment was performed with 4 repeats.
Wound healing assay. Alterations of the migration capabilities of sEV-exposed B16F1 and bEnd.3 cells 
were assessed by scratch assay. Nearly confluent monolayers of cells were scratch wounded using a sterile 200 µl 
pipette tip, washed 3 times with culture media to remove cellular debris, then treated with 200 µg/ml sEV suspen-
sions or PBS in fresh complete media. Wound closure was followed until the cell-free area decreased below 10% in 
at least 1 sample, when images were taken by an inverted microscope (Zeiss, Axiovert S100) equipped by a Nikon 
D5000 camera. Grey-scaled images were analysed using the MRI Wound Healing Tool in the ImageJ software. 
The experiment was repeated 8 times for B16F1 cells, and 4 times for bEnd.3 cells.
Analysis of microtissue generation. Effects of different sEVs on cell-cell contact and cell-ECM interac-
tions was examined on MSC-B16F1 and MEF-B16F1 co-cultures using a simplified 3D tumour matrix model to 
better represent the in vivo conditions, than 2D cultures. Equal number of MSCs or MEFs and B16F1 cells were 
seeded to 96-well GravityPLUS hanging drop plates (InSphero AG) in sEV- or PBS-containing media (5,000 
cell/40 µl/well). Microtissue generation was followed for 72 h and images were acquired in every 24 h using an 
Axiovert S100 microscope (Zeiss) equipped by a Nikon D5000 camera. To quantify differences in size and shape 
between the microtissues, 72 h images were grey scaled and analysed by the AnaSP software79. Measured param-
eters of microtissues were the equivalent diameter, major diameter through centroid, minor diameter through 
centroid, convexity, solidity, sphericity, area, perimeter and volume. The experiments were repeated 3 times.
Statistical analysis. Since the homogeneity of variances assumption of the ANOVA had not met with our data, 
statistical analyses were performed by the Welch’s ANOVA test with Tukey’s HSD post-hoc test (Alpha = 0.05) using 
a Microsoft Excel add-in, the Real Statistics Resource Pack software (Release 5.4). Copyright (2013–2018) Charles 
Zaiontz (www.real-statistics.com). Diagrams were prepared in GraphPad Prism 5.03. All average values represent 
mean ± SD and number of asterisk denote minimum statistical significance, i.e. *p < 0.05, **p < 0.01 and ***p < 0.001 
on figures. Exact p-values are indicated in the text, when it is necessary. Figure 1 was created with BioRender.com.
Data availability
All datasets generated during the current study are available from the corresponding author upon reasonable 
request.
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